UnitedHealth Will Be More Aggressive In Part D Pharmaceutical Contracting
Executive Summary
UnitedHealth Group plans to leverage the scale of its Part D business to produce "significant decreases" in its cost structure for the program in 2007, Chairman and CEO William McGuire said during the company's second quarter earnings call July 19
You may also be interested in...
UnitedHealth, PacifiCare To Pursue Separate Courses For Part D After Merger
UnitedHealth Group and PacifiCare will adopt separate strategies for introducing Medicare Part D prescription drug plans notwithstanding a July 6 announcement that the two health care providers will merge
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials